Outsourcing

When Is It Appropriate to Outsource Bioanalysis Work to a CRO?

When considering whether to outsource work to a CRO, there are a number of factors to assess, including the type of work that may be outsourced, regulatory considerations, and needs for the study.

Fostering Orphan Drugs

CDMOs offer expertise and customization options for sponsors of orphan drugs.

Balancing Internal Focus Against External Capabilities

Demand for outsourced services of technical R&D activities is increasing.

When Is It Appropriate to Outsource Bioanalysis Work to a CRO?

June 01, 2022

When considering whether to outsource work to a CRO, there are a number of factors to assess, including the type of work that may be outsourced, regulatory considerations, and needs for the study.

Productive Client-CDMO Relationships

June 01, 2022

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the basics for maintaining an acceptable working relationship between a client and their CDMO.

Thermo Fisher Scientific and LabShares Partner to Support Emerging Boston Biotechs

May 31, 2022

Through the Thermo Fisher Scientific and LabShares Newton partnership, life science startups can accelerate early-stage discovery and development with shared lab spaces.

PerkinElmer Introduces Ultrarapid Whole Genome Sequencing

May 31, 2022

PerkinElmer has expanded its genomics testing services with the launch of its ultrarapid whole genome sequencing.

Lonza, IBF Collaborate to Support Development and Manufacturing of Biologics and Small Molecules

May 26, 2022

Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.

Balancing Internal Focus Against External Capabilities

May 19, 2022

Demand for outsourced services of technical R&D activities is increasing.

The Essential Ingredient in any Sponsor-CRO Partnership: Trust

May 16, 2022

To build trust and ensure a high-quality product, companies must be sure their contracts are firm and their lines of communication even firmer.

Fostering Orphan Drugs

May 15, 2022

CDMOs offer expertise and customization options for sponsors of orphan drugs.

Preparing for the Future: Expanding Capacity and Facilitating Multi-modalities

May 15, 2022

CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.

The CDMO Carousel

May 15, 2022

Acquisitions in the CDMO space can give us insight into a company's vision for their future.